Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke

Table 3 Mortality at 3 and 12 months and cardiovascular events in patients using aspirin + dipyridamole (A + D) vs. use of aspirin only (A) after acute stroke/TIA (%)

	3-mo	12-mo	3-mo CVD	12-mo CVD
Aspirin + Dipyridamole	1.1	5.7**	5.7	14.7
(n = 275)
Aspirin only	5.7	10.7	3.8	10.9
(n = 262)

** = P < 0.01 for comparison A + D vs.A only, : mortality, CVD: Cardiovascular Disease (recurring stroke/TIA, non-fatal myocardial infarction, congestive heart failure, ischemic heart disease), 3-mo: 3-months mortality; 12-mo: 12-months mortality. Results are presented in percent(%).

ISSN: 1471-2377